Li, F., Liu, Z., Sun, H., Li, C., Wang, W., Ye, L., . . . Wang, H. (2020). PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo. Acta Pharm Sin B.
Stile di citazione ChicagoLi, Fangfang, Zongliang Liu, Heyuan Sun, Chunmei Li, Wenyan Wang, Liang Ye, Chunhong Yan, Jingwei Tian, e Hongbo Wang. "PCC0208017, a Novel Small-molecule Inhibitor of MARK3/MARK4, Suppresses Glioma Progression In vitro and In vivo." Acta Pharm Sin B 2020.
Citazione MLALi, Fangfang, et al. "PCC0208017, a Novel Small-molecule Inhibitor of MARK3/MARK4, Suppresses Glioma Progression In vitro and In vivo." Acta Pharm Sin B 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.